Coeptis Therapeutics, Inc.COEPNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-10.05M
Near historical average
Average (8y)
$-9.66M
Historical baseline
Range
High:$0.00
Low:$-34.20M
CAGR
+137.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-10.05M | +53.2% |
| 2023 | $-21.49M | +37.2% |
| 2022 | $-34.20M | -143.5% |
| 2021 | $-14.05M | -104.7% |
| 2020 | $-6.86M | - |
| 2019 | $0.00 | - |
| 2018 | $0.00 | +100.0% |
| 2005 | $-308000.00 | -2956.5% |
| 2004 | $-10077.00 | - |